Clinical Trials Directory

Trials / Completed

CompletedNCT04409392

Staphylococcus Lugdunensis Prosthetic Joint Infection

Staphylococcus Lugdunensis Prosthetic Joint Infection: a Retrospective Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
84 (actual)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Staphylococcus lugdunensis is a coagulase-negative staphylococcus belonging to the human commensal cutaneous flora, and has been little studied in the field of prosthetic joint infections. However, it shares many virulence traits with Staphylococcus aureus, including many adhesins and its ability to form biofilm, and the few series of cases reports a significant failure rate.

Conditions

Interventions

TypeNameDescription
OTHERProthestic joint infection due to Staphylococcus lugdunensisdescription of prosthetic joint infection with Staphylococcus lugdunensis

Timeline

Start date
2021-02-01
Primary completion
2021-04-01
Completion
2021-04-01
First posted
2020-06-01
Last updated
2021-06-16

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04409392. Inclusion in this directory is not an endorsement.